Introduction Canvassing venues where people meet social or sexual partners is an effective and efficient means of identifying syphilis cases for transmission control and may be important to access MSM at high risk for HIV transmission for PrEP delivery. The objective was to determine variability in the frequency of report and transmission risk across sex partner meeting venues reported by HIV and/or syphilis positive MSM. Methods Routinely reported public health surveillance data from early syphilis and/or HIV positive MSM between 2009-2015 in a U.S. mid-Atlantic city were utilised. Past 3 month sex partner meeting venues were collected as a part of routine partner services. Venue geometric mean syphilis titer load (VTL) and HIV viral load (VVL) were calculated and tested using generalised linear additive models with random effects. Results There were 1870 cases-63%(1177) syphilis, 37%(693) HIV. 88% (1641) were interviewed; among these, 48% (790) reported >1 venue and were on average aged 31(SD10), 78% (615) Black. Cases reported 1331 venues (avg 2, range 1-16 per case). Syphilis and HIV cases reported 940 (avg 2, range 1-16) and 449 venues (avg 2, range 1-7). Overall and by syphilis and HIV cases, 43%(577), 45%(415) and 46% (208) of reports were for the highest frequency venues (n=9); 3 internet venues accounted for 66% of reports. Among the top frequency venues (n=9, reports n=577), there was significant (p<0.001) variability in the report frequency for venues overall (Chi square(CS) 314.7) and by syphilis (CS 225.5) and HIV cases (CS 130). 68% (642) of syphilis cases had an RPR titer and the VTL was significantly variable (CS 2252.9, p<0.001). 35% (159) of HIV cases had an HIV viral load, and there was not significant variability (CS 5.3, p=0.725) . Conclusion Sex partner meeting venues are similar for syphilis and HIV positive MSM suggesting overlapping transmission networks, although the variability of their report differs. Significant differences venue TL suggest targeting specific venues may be important for transmission control and prevention strategies. 2 Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service (GGD), Geleen, The Netherlands Introduction: Mycoplasma genitalium (MG) is increasingly seen as a clinically relevant sexually transmitted infection (STI), with a clinical spectrum similar to Chlamydia trachomatis (CT) and Neisseria gonorhoeae, including pelvic inflammatory disease and adverse reproductive outcomes. In the Netherlands, MG testing is not currently recommended for first-line STI screening despite a~4% background prevalence. Very little is known about co-infections with CT or NG as patients are usually only tested after negative CT/NG tests. We therefore studied the co-occurrence of MG and CT in both low-and high-prevalence populations. Methods 1024 CT-positive participants from the Dutch general population (participants in the Chlamydia Screening Intervention-study) (60.3%; 462 ♀) and STI-clinic in South Limburg, the Netherlands (39.6%; 259 ♀) were retrospectively tested for MG. Men provided urine samples and women selfcollected vaginal swabs. Samples were tested for human cells to ensure adequate sampling. CT/MG co-infections were investigated and correlated to symptoms. Statistical testing was performed using Chi-square test. Results Of 1024 CT-positive patients, 5.5% had a co-infection with MG. CT/MG co-infections were present in 6.3% of the general population, compared to 4.2% of STI-clinic visitors. 3.9% of STI-clinic women had a CT/MG co-infection, compared to 7.4% in the general population. STI-clinic and general population men had a similar MG prevalence of 3.2% and 4.7%. Symptoms were reported by 37.3% of patients; 37.2% in single CT-infections and 39.3% in CT/MG coinfections. Conclusion CT/MG co-infections are at least as common (5.5%), and in some populations more common (up to 7.4%), than in the general (CT-negative) population. As MG-testing is currently not routine practice in most clinics, these women go undiagnosed and receive inferior treatment, which likely contributes to current 30%-45% azithromycin resistance in MG. However, the higher prevalence of MG in the general population and the similar frequency of symptoms in both groups questions the clinical relevance of this pathogen. Introduction Between 2012 and 2014, rates of congenital syphilis increased in Louisiana (LA) (from 52.7 to 73.4 cases per 1 00 000 live births) and Florida (FL) (from 17.4 to 22.1 cases per 1 00 000 live births) ranking them among the highest in the United States. Both states have rules and regulations that require testing pregnant women for syphilis during the first trimester, early third trimester, and at delivery. We evaluated the effectiveness of early and third trimester syphilis screening for the prevention of congenital syphilis in these high-morbidity states. Methods Reported syphilis cases among pregnant women in FL and LA during January 1, 2013-December 31, 2014, were reviewed for documented screening for syphilis in the first two trimesters and the third trimester. Pregnant women with syphilis were linked to congenital syphilis records and stratified by whether their pregnancy led to a reported congenital syphilis case. Results 710 pregnant women with syphilis in LA and FL led to 155 congenital syphilis cases. 555 (78%) potential congenital syphilis cases were averted. 370 (52%) of the pregnant women with syphilis were staged as early syphilis or high-titer late-latent syphilis, and they were linked to 109 (70%) of the congenital syphilis cases. 513 pregnant women tested positive for syphilis in the first two trimesters and 470 (92%) of them had babies without congenital syphilis. Of the remaining 197 women, 109 tested positive for syphilis in the third trimester, and 85 (78%) of them had babies without congenital syphilis. 39 (6%) women had no reported syphilis screening !30 days
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